Health product recall

Privigen: Series of adverse reactions

Last updated

Summary

Product
Privigen
Issue
Health products - Adverse reaction
What to do

Consult your health care professional if you have any health concerns.

Affected products

Brand Product Name Market Authorization Dosage Form Strength Lot
Privigen Privigen DIN 02304619 Liquid Immunoglobulin Intravenous (Human), 10% P100543004

Issue

Affected lot being voluntarily recalled due to a series of adverse reactions.

What you should do

  1. Verify if your product is affected.
  2. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
  3. Contact the recalling firm if you have any questions about the recall.
  4. Report any health product related side effects to Health Canada.
  5. Report any other health product safety complaints to Health Canada.

Additional information

Background

Depth of recall: Healthcare Establishments

Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies

CSL Behring Canada Inc.
1460- 55 Metcalfe Street
Ottawa, Ontario
K1P 6L5

Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type II
Identification number
RA-74785

Get notified

Receive notifications for new and updated recalls and alerts by category.

Subscribe